Thoracic radiotherapy for limited-stage small-cell lung cancer: controversies and future developments.
AffiliationClinical Oncology Department, Christie Hospital NHS Trust, Manchester, UK. email@example.com
MetadataShow full item record
AbstractThoracic radiotherapy has an established role in the management of limited-disease small-cell lung cancer (LD SCLC). However, essential questions relating to the optimisation of thoracic radiotherapy remain unanswered, including volume of irradiation, optimal total dose, fractionation, timing and sequencing of radiation. This review highlights the need for well-designed multi-national trials aimed at the optimisation and standardisation of radiotherapy for LD SCLC.
CitationThoracic radiotherapy for limited-stage small-cell lung cancer: controversies and future developments. 2005, 17 (8):591-8 Clin Oncol
- Radiotherapy for small-cell lung cancer-Where are we heading?
- Authors: Bayman NA, Sheikh H, Kularatne B, Lorigan P, Blackhall F, Thatcher N, Faivre-Finn C
- Issue date: 2009 Mar
- [Treatment of small cell lung cancer: limited diseases. Guidelines of clinical practice made by the European Lung Cancer Working Party].
- Authors: European Lung Cancer Working Party.
- Issue date: 2008 May-Jun
- Thoracic irradiation of limited small cell lung cancer: have we defined optimal dose, time, and fractionation?
- Authors: Wagner H Jr
- Issue date: 1997 Jun
- The role of thoracic radiotherapy in the management of limited-stage small cell lung cancer: past, present, and future.
- Authors: Kumar P
- Issue date: 1997 Oct
- Platinum combined with radiation therapy in small cell lung cancer: focusing like a laser beam on crucial issues.
- Authors: Turrisi AT 3rd
- Issue date: 1994 Jun